Published in J Neurosurg on November 01, 2009
Neurocognitive dysfunction in adult moyamoya disease. J Neurol (2009) 0.96
Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with moyamoya disease. Neurosurg Rev (2011) 0.92
Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in Moyamoya disease: A review of the literature. Surg Neurol Int (2012) 0.86
Management of distal choroidal artery aneurysms in patients with moyamoya disease: report of three cases and review of the literature. World J Surg Oncol (2013) 0.78
Long-term Outcome of Motor Function in a Child with Moyamoya Disease: A Case Report. J Phys Ther Sci (2014) 0.78
Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals. Neurosurgery (2010) 0.76
Moyamoya syndrome in a known case of pulmonary tuberculosis. J Neurosci Rural Pract (2010) 0.75
One sided bypass for bilateral Moyamoya disease, a case report and review of the literatures. Int J Surg Case Rep (2016) 0.75
Adult moyamoya disease in an urban center in the United States is associated with a high burden of watershed ischemia. J Am Heart Assoc (2014) 0.75
The Efficacy of Single Barrel Superficial Temporal Artery-middle Cerebral Artery Bypass in Treatment of Adult Patients with Ischemic-type Moyamoya Disease. J Cerebrovasc Endovasc Neurosurg (2016) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84
Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol (1969) 6.86
Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke (2007) 2.08
Clinical features of moyamoya disease in the United States. Stroke (1998) 1.91
Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke (2006) 1.68
Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke (2005) 1.35
A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke (1997) 1.25
Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke (1997) 1.22
Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg (1992) 1.22
The Moyamoya syndrome and the neurosurgeon. Surg Neurol (1975) 1.08
Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg (1997) 1.06
The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg (2009) 1.04
Moyamoya disease: the disorder and surgical treatment. Mayo Clin Proc (1994) 1.03
Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures. Neurosurgery (1992) 1.02
Cranial burr hole for revascularization in moyamoya disease. J Neurosurg (1989) 1.01
Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg (1997) 0.98
Cerebral vascular accidents in patients over the age of 60. III. Diagnosis and treatment. Scott Med J (1957) 0.90
Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg (1997) 0.87
Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? Surg Neurol (1996) 0.87
Prospective study of neuropsychological and psychosocial outcome following surgical excision of intracerebral arteriovenous malformations. J Clin Neurosci (2003) 0.86
Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol (2003) 0.85
[Moyamoya disease(author's transl)]. Neurol Med Chir (Tokyo) (1979) 0.84
Management of patients with symptomatic carotid artery occlusion. Clin Exp Hypertens (2002) 0.82
Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients--swift disappearance of ischemic attacks and maintenance of mental capacity. Neurol Med Chir (Tokyo) (1991) 0.79
[Effects of indirect EC/IC bypass operations on adult moyamoya patients]. No Shinkei Geka (1986) 0.79
Thomas Willis Lecture. Acute clinical trials: An expression of concern. Cerebrovasc Dis (1999) 0.79
Perioperative complications of encephalo-duro-arterio-synangiosis: prevention and treatment. Surg Neurol (1991) 0.78
[Hemorrhagic type of moyamoya disease]. No Shinkei Geka (1991) 0.78
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol (2010) 3.49
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Managing intracranial incidental findings suggestive of low-grade glioma: learning from experience. World Neurosurg (2012) 2.84
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery (2006) 2.33
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
The role of preoperative embolization for intracranial meningiomas. J Neurosurg (2013) 2.29
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci (2002) 2.25
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg (2010) 2.15
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev (2009) 2.11
Pathophysiology of acute hydrocephalus after subarachnoid hemorrhage. World Neurosurg (2013) 2.05
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med (2007) 1.97
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89
Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation (2005) 1.88
Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair (2007) 1.86
Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol (2011) 1.85
Ventriculostomy-related infections: a critical review of the literature. Neurosurgery (2002) 1.84
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
Carotid-cavernous fistulas. Neurosurg Focus (2012) 1.76
Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med (2004) 1.76
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke (2010) 1.72
Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care (2008) 1.69
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results. Neurology (2014) 1.65
Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65
Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 1.65
Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 1.63
Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology (2007) 1.61
Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61
Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61
Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA (2004) 1.58
Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol (2004) 1.55
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
Treatment guidelines for cerebral arteriovenous malformation microsurgery. Br J Neurosurg (2009) 1.54
The surgical management of chronic subdural hematoma. Neurosurg Rev (2011) 1.54
Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg (2012) 1.53
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52
Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52
Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery (2005) 1.51
Radiographic evidence of cerebral hyperperfusion and reversal following angioplasty and stenting of intracranial carotid and middle cerebral artery stenosis: case report and review of the literature. J Neuroimaging (2009) 1.50
Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery (2006) 1.49
Conducting stroke research with an exception from the requirement for informed consent. Stroke (2003) 1.49
Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study. J Hypertens (2015) 1.48
Radiation exposure of the anesthesiologist in the neurointerventional suite. Anesthesiology (2011) 1.47
Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol (2005) 1.47
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg (2012) 1.45